Drugs in the Pipeline
Tecarfarin is a novel oral vitamin K antagonist with a similar mechanism of action to warfarin, though it is metabolized differently.
Drugs in the Pipeline
MK-2060 is an investigational monoclonal antibody designed to inhibit the activation of Factor XI and its ability to activate downstream proteins.
News
In patients whose tumors had ESR1 mutations, elacestrant reduced the risk of progression or death by 45%.
News
EndoClot PHS is a single-use device consisting of a starch-based powder hemostat to control bleeding in the GI tract.
